Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Cooper

Showing results (231-240 of 319) with videos related to

Pageof 32
Sort By:
Sexually Transmitted Diseases|December 8, 2025
Myocarditis and Pericarditis as a Complication of Mpox: Case Series and Literature ReviewSheliza Halani, Sean Cai, Catherine Zanoria, et al.
Journal of Virology|October 19, 2007
Attenuation of recombinant vesicular stomatitis virus-human immunodeficiency virus type 1 vaccine vectors by gene translocations and g gene truncation reduces neurovirulence and enhances immunogenicity in miceDavid Cooper, Kevin J Wright, Priscilla C Calderon, et al.
Biorxiv : the Preprint Server for Biology|April 8, 2025
Single-dose administration of therapeutic divalent siRNA targeting MECP2 prevents lethality for one year in an MECP2 duplication mouse modelVignesh N Hariharan, Ashley Summers, Amy E Clipperton-Allen, et al.
Health Technology Assessment (Winchester, England)|August 16, 2022
Synthetic sling or artificial urinary sphincter for men with urodynamic stress incontinence after prostate surgery: the MASTER non-inferiority RCTLynda Constable, Paul Abrams, David Cooper, et al.
Molecular Therapy. Nucleic Acids|September 5, 2024
Identification of selective and non-selective <i>C9ORF72</i> targeting <i>in vivo</i> active siRNAsJames W Gilbert, Zachary Kennedy, Bruno M D C Godinho, et al.
Open Forum Infectious Diseases|July 21, 2025
Dynamics of Respiratory Syncytial Virus Illness and Serology During Pregnancy and Infancy in the United States and South AfricaShabir A Madhi, Eric A F Simões, Nicola P Klein, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 22, 2023
Safety and Immunogenicity of Bivalent RSVpreF Vaccine Coadministered With Seasonal Inactivated Influenza Vaccine in Older AdultsEugene Athan, James Baber, Karen Quan, et al.
Research Square|May 2, 2025
Single-dose administration of therapeutic divalent siRNA targeting MECP2 prevents lethality for one year in an MECP2 duplication mouse modelVignesh N Hariharan, Ashley Summers, Amy E Clipperton-Allen, et al.
Lancet (London, England)|April 10, 2007
Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trialsBonaventura Clotet, Nicholas Bellos, Jean-Michel Molina, et al.
Trials|February 23, 2018
Male synthetic sling versus artificial urinary sphincter trial for men with urodynamic stress incontinence after prostate surgery (MASTER): study protocol for a randomised controlled trialLynda Constable, Nikki Cotterill, David Cooper, et al.
Pageof 32

Showing results (231-240 of 319) with videos related to

Sort By:
Pageof 32
Sexually Transmitted Diseases|December 8, 2025
Myocarditis and Pericarditis as a Complication of Mpox: Case Series and Literature ReviewSheliza Halani, Sean Cai, Catherine Zanoria, et al.
Journal of Virology|October 19, 2007
Attenuation of recombinant vesicular stomatitis virus-human immunodeficiency virus type 1 vaccine vectors by gene translocations and g gene truncation reduces neurovirulence and enhances immunogenicity in miceDavid Cooper, Kevin J Wright, Priscilla C Calderon, et al.
Biorxiv : the Preprint Server for Biology|April 8, 2025
Single-dose administration of therapeutic divalent siRNA targeting MECP2 prevents lethality for one year in an MECP2 duplication mouse modelVignesh N Hariharan, Ashley Summers, Amy E Clipperton-Allen, et al.
Health Technology Assessment (Winchester, England)|August 16, 2022
Synthetic sling or artificial urinary sphincter for men with urodynamic stress incontinence after prostate surgery: the MASTER non-inferiority RCTLynda Constable, Paul Abrams, David Cooper, et al.
Molecular Therapy. Nucleic Acids|September 5, 2024
Identification of selective and non-selective <i>C9ORF72</i> targeting <i>in vivo</i> active siRNAsJames W Gilbert, Zachary Kennedy, Bruno M D C Godinho, et al.
Open Forum Infectious Diseases|July 21, 2025
Dynamics of Respiratory Syncytial Virus Illness and Serology During Pregnancy and Infancy in the United States and South AfricaShabir A Madhi, Eric A F Simões, Nicola P Klein, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 22, 2023
Safety and Immunogenicity of Bivalent RSVpreF Vaccine Coadministered With Seasonal Inactivated Influenza Vaccine in Older AdultsEugene Athan, James Baber, Karen Quan, et al.
Research Square|May 2, 2025
Single-dose administration of therapeutic divalent siRNA targeting MECP2 prevents lethality for one year in an MECP2 duplication mouse modelVignesh N Hariharan, Ashley Summers, Amy E Clipperton-Allen, et al.
Lancet (London, England)|April 10, 2007
Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trialsBonaventura Clotet, Nicholas Bellos, Jean-Michel Molina, et al.
Trials|February 23, 2018
Male synthetic sling versus artificial urinary sphincter trial for men with urodynamic stress incontinence after prostate surgery (MASTER): study protocol for a randomised controlled trialLynda Constable, Nikki Cotterill, David Cooper, et al.
Pageof 32